TCTR20160426004已完成3 期
Effect of the subcutaneous low molecular weight heparin injection technique on bruising and pain
Siriraj Resarch Development Fund0 个研究点目标入组 44 人开始时间: 2016年4月26日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 44
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 80 Years(—)
- 性别
- All
入选标准
- •age 18- 80 y
- •Outpatient who receive Enoxaparin 1 mg/kg twice daily
排除标准
- •-Patients who have mental disorder that affects the brain and perception.
- •-receiving the drug. anticoagulant and antiplatelet addition
- •-Creatinine clearance < 30 ml/mi,Platelet ≤ 100,000 /ul,APTT ≤ 23 or ≥ 32 sec, PT ≤ 11 or ≥ 14 sec
- •-pregnancy or breastfeeding
- •-cann't follow up
研究者
相似试验
已完成
不适用
Subcutaneously administered low molecular weight heparin for anticoagulation in patients undergoing lung transplantation with periprocedural ECMO support - a retrospective, observational cohort study.lung transplantationextracorporeal membrane oxygenationZ94.2Lung transplant statusDRKS00013593Medizinische Universität WienUniversitätsklinik für Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie102
已完成
2 期
Comparative evaluation the effect of preemptive subcutaneous infiltration of two doses of tramadol on post-operative pain of open kidney and urinary tract surgeriespost-operative pain after open urologic surgeries.IRCT138804222159N1Isfahan University of Medical Sciences96
进行中(未招募)
1 期
Safety and Efficacy of Heparin for 72 Hours Followed by Dabigatran for the Treatment of Acute Pulmonary Embolism.EUCTR2015-001830-12-ATniversity Medical Center of the Johannes Gutenberg University Mainz700
进行中(未招募)
1 期
Safety and Efficacy of Heparin for 72 Hours Followed by Dabigatran for the Treatment of Acute Pulmonary Embolism.Acute Intermediate-Risk Pulmonary EmbolismMedDRA version: 19.0Level: HLTClassification code 10037379Term: Pulmonary embolism and thrombosisSystem Organ Class: 100000004866EUCTR2015-001830-12-NLniversity Medical Center of the Johannes Gutenberg University Mainz700
进行中(未招募)
1 期
Safety and Efficacy of Heparin for 72 Hours Followed by Dabigatran for the Treatment of Acute Pulmonary Embolism.Acute Intermediate-Risk Pulmonary EmbolismMedDRA version: 20.0Level: HLTClassification code 10037379Term: Pulmonary embolism and thrombosisSystem Organ Class: 100000004866EUCTR2015-001830-12-ITIVERSITY MEDICAL SCHOOL OF THE JOHANNES GUTENBERG UNIVERSITY MAINZ530
